Comments
Here are answers to readers’ queries on the performance of their stock holdings.
I bought shares of Jubilant Life Sciences and HSIL at ₹658 and ₹378, respectively. Should I average my cost by buying at the current prices. What are the long-term prospects for these stocks?
Rajeev Kumar
Jubilant Life Sciences (₹447.2): The stock of Jubilant Life Sciences has been in a medium-term downtrend since encountering a key resistance at around ₹900 this March.
It breached a key support at ₹625 in May and witnessed a sharp fall, resuming the intermediate-term downtrend that has been in place since registering a new high at ₹1,039 in February 2018.
Short-term trend is also down. But the stock appears to have found support at the long-term base in the band between ₹410 and ₹425 recently.
The stock is currently poised above this long-term support band.
The weekly relative strength index and the price rate of change indicators display positive divergence, which implies trend reversal on the cards.
With the stock hovering at a key long-term support and the indicators projecting a trend reversal, a short-term rally is possible in the stock now.
You can consider averaging the stock with a stop-loss at ₹410.
A strong break above the immediate resistance level of ₹500 will alter the short-term downtrend and take the stock up to ₹550 and ₹600 levels in the medium term.
The significant long-term resistance is in the ₹625-650 band.
An emphatic break above this barrier will alter the medium-term downtrend and take the stock up to ₹700.
Subsequent vital resistance is at ₹750 and ₹800. Inability to move beyond ₹650 will be cue for booking partial profits.
On the downside, a decisive tumble below ₹410 will reinforce the downtrend and drag the stock to ₹380 and ₹350 levels.
A further fall below ₹350 will pull it down to ₹300.
In such a scenario, avoid taking fresh positions and average at lower levels.
HSIL (₹234.5): The stock of HSIL gained 4 per cent on Friday and managed to close above the 21-day moving average.
Although the stock is in a downtrend across all-time frames, there are signs of short-term trend reversal.
The daily relative strength index shows positive divergence and has entered the neutral region from the bearish zone.
Key support provides base at ₹210. Nevertheless, the stock faces a crucial resistance at ₹250.
A conclusive break above this level will take the stock up to ₹270 and ₹300. Consider averaging in declines with a stop-loss at ₹190 and book partial profits at ₹300.
An emphatic break above the long-term barrier at ₹300 is needed to alter the medium-term downtrend and take the stock up to ₹325 and ₹350 levels.
Send your queries to techtrail@thehindu.co.in
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.